VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+40.5%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$47M
AUM Growth
+$47M
(-92%)
Cap. Flow
-$548M
Cap. Flow
% of AUM
-1,166.74%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
310
New
6
Increased
35
Reduced
92
Closed
151
Top Buys
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$515K |
| 2 |
Franklin FTSE India ETF
FLIN
|
$355K |
| 3 |
Puma Biotechnology
PBYI
|
$276K |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$255K |
| 5 |
Enanta Pharmaceuticals
ENTA
|
$238K |
Top Sells
| 1 |
MPLX
MPLX
|
$60.3M |
| 2 |
EQM
EQM Midstream Partners, LP
EQM
|
$58.3M |
| 3 |
Energy Transfer Partners
ET
|
$49.7M |
| 4 |
Enterprise Products Partners
EPD
|
$41.7M |
| 5 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$30.5M |
Sector Composition
| 1 | Healthcare | 88.12% |
| 2 | Financials | 0.73% |
| 3 | Communication Services | 0.52% |
| 4 | Consumer Discretionary | 0.46% |
| 5 | Materials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONCE
1
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $2.25M | 4.79% | 19,751 +4,520 | +30% | +$515K |
|
|
2
Puma Biotechnology
PBYI
$254M
| $1.3M | 2.76% | 33,378 +7,119 | +27% | +$276K |
|
|
ARRY
3
DELISTED
Array Biopharma Inc
ARRY
| $1.19M | 2.54% | 48,922 +10,443 | +27% | +$255K |
|
4
Ultragenyx Pharmaceutical
RARE
$2.89B
| $1.14M | 2.42% | 16,385 +3,235 | +25% | +$224K |
|
|
5
Enanta Pharmaceuticals
ENTA
$180M
| $1.02M | 2.16% | 10,634 +2,494 | +31% | +$238K |
|
|
MNTA
6
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $1.01M | 2.14% | 69,315 +16,033 | +30% | +$233K |
|
7
Amicus Therapeutics
FOLD
$2.34B
| $1M | 2.13% | 73,653 +16,226 | +28% | +$221K |
|
8
Incyte
INCY
$16.5B
| $990K | 2.11% | 11,513 +2,440 | +27% | +$210K |
|
9
Agios Pharmaceuticals
AGIO
$2.19B
| $981K | 2.09% | 14,540 +3,009 | +26% | +$203K |
|
10
Alnylam Pharmaceuticals
ALNY
$58.5B
| $959K | 2.04% | 10,262 +2,399 | +31% | +$224K |
|
11
Neurocrine Biosciences
NBIX
$13.8B
| $940K | 2% | 10,671 +2,386 | +29% | +$210K |
|
12
Ironwood Pharmaceuticals
IRWD
$214M
| $931K | 1.98% | 68,811 +15,989 | +30% | +$216K |
|
13
Exelixis
EXEL
$10.1B
| $867K | 1.84% | 36,441 +7,624 | +26% | +$181K |
|
14
Regeneron Pharmaceuticals
REGN
$61.5B
| $850K | 1.81% | 2,071 +480 | +30% | +$197K |
|
15
United Therapeutics
UTHR
$13.8B
| $831K | 1.77% | 7,084 +1,548 | +28% | +$182K |
|
16
Halozyme
HALO
$8.56B
| $818K | 1.74% | 50,835 +10,900 | +27% | +$175K |
|
17
Vertex Pharmaceuticals
VRTX
$100B
| $814K | 1.73% | 4,427 +892 | +25% | +$164K |
|
|
ICPT
18
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $798K | 1.7% | 7,138 +1,578 | +28% | +$176K |
|
19
BioMarin Pharmaceuticals
BMRN
$11.2B
| $736K | 1.57% | 8,285 +1,832 | +28% | +$163K |
|
20
Ligand Pharmaceuticals
LGND
$3.15B
| $692K | 1.47% | 5,503 +1,181 | +27% | +$149K |
|
|
21
Franklin FTSE India ETF
FLIN
$2.28B
| $668K | 1.42% | 28,491 +15,153 | +114% | +$355K |
|
22
Theravance Biopharma
TBPH
$699M
| $649K | 1.38% | 28,612 +6,169 | +27% | +$140K |
|
|
ACOR
23
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $644K | 1.37% | 48,468 +11,357 | +31% | +$151K |
|
|
NITE
24
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $603K | 1.28% | 23,777 -3,500 | -13% | -$88.8K |
|
25
uniQure
QURE
$896M
| $569K | 1.21% | 9,543 -1,135 | -11% | -$67.7K |
|